ChipMOS TECHNOLOGIES (IMOS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IMOS SEC filings page.
ChipMOS TECHNOLOGIES INC (IMOS) reported $762.9M in revenue for fiscal year 2025, up 10.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue recovery arrived in FY2025, but profits and cash generation weakened sharply while investment still consumed nearly all operating cash.
Revenue rose10.2% in FY2025 while net income fell60.0% ; the sales rebound therefore did not reach the bottom line. Operating cash flow fell29.7% and free cash flow fell82.3% , showing that earnings deterioration also weakened cash available after investment.
Gross margin fell from
Debt-to-equity fell from 0.4x in FY2024 to 0.0x in FY2025, reducing reliance on long-term borrowing. However, current liabilities grew
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of ChipMOS TECHNOLOGIES INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
ChipMOS TECHNOLOGIES INC's revenue grew 10.2% year-over-year to $762.9M, a solid pace of expansion. This earns a growth score of 48/100.
ChipMOS TECHNOLOGIES INC carries a low D/E ratio of 0.03, meaning only $0.03 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 86/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 2.40, ChipMOS TECHNOLOGIES INC holds $2.40 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 68/100.
While ChipMOS TECHNOLOGIES INC generated $127.4M in operating cash flow, capex of $122.8M consumed most of it, leaving $4.6M in free cash flow. This results in a low score of 44/100, reflecting heavy capital investment rather than weak cash generation.
ChipMOS TECHNOLOGIES INC's ROE of 2.3% shows moderate profitability relative to equity, earning a score of 41/100. This is down from 5.8% the prior year.
ChipMOS TECHNOLOGIES INC passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, ChipMOS TECHNOLOGIES INC generates $7.26 in operating cash flow ($127.4M OCF vs $17.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
ChipMOS TECHNOLOGIES INC generated $762.9M in revenue in fiscal year 2025. This represents an increase of 10.2% from the prior year.
ChipMOS TECHNOLOGIES INC reported $17.6M in net income in fiscal year 2025. This represents a decrease of 60.0% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
ChipMOS TECHNOLOGIES INC generated $4.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 82.3% from the prior year.
ChipMOS TECHNOLOGIES INC held $473.7M in cash against $23.6M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
ChipMOS TECHNOLOGIES INC's net profit margin was 2.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 4.0 percentage points from the prior year.
ChipMOS TECHNOLOGIES INC's ROE was 2.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.5 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
ChipMOS TECHNOLOGIES INC invested $122.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 20.8% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
IMOS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $762.9M+10.2% | $692.2M-0.8% | $697.5M-8.9% | $765.3M-22.5% | $987.7M+20.5% | $819.5M+20.5% | $680.0M+12.6% | $603.7M-0.3% | $605.3M |
| Cost of Revenue | N/A | $602.4M+3.6% | $581.5M-3.9% | $605.4M-16.6% | $726.2M+13.4% | $640.3M+16.7% | $548.7M+11.6% | $491.7M-0.9% | $496.1M |
| Gross Profit | N/A | $89.8M-22.5% | $115.9M-27.5% | $159.8M-38.9% | $261.5M+45.9% | $179.2M+36.5% | $131.3M+17.1% | $112.1M+2.6% | $109.2M |
| R&D Expenses | N/A | $35.5M-0.7% | $35.7M-5.3% | $37.7M-8.2% | $41.1M+13.6% | $36.2M+7.4% | $33.7M+9.8% | $30.7M-7.7% | $33.3M |
| Operating Income | N/A | $38.9M-37.7% | $62.3M-40.5% | $104.7M-47.8% | $200.5M+57.9% | $127.0M+54.6% | $82.2M+19.8% | $68.6M-9.2% | $75.6M |
| Interest Expense | N/A | $8.5M-2.2% | $8.7M+87.4% | $4.6M+6.3% | $4.4M-24.6% | $5.8M+1.1% | $5.7M+14.9% | $5.0M-22.5% | $6.4M |
| Income Tax | $1.3M-79.8% | $6.3M-35.5% | $9.8M-48.7% | $19.1M-51.7% | $39.6M+87.0% | $21.2M+23.3% | $17.2M+15.1% | $14.9M-19.7% | $18.6M |
| Net Income | $17.6M-60.0% | $43.9M-31.7% | $64.3M-42.6% | $111.9M-37.1% | $178.0M+110.1% | $84.7M+1.0% | $83.9M+93.6% | $43.3M-54.1% | $94.4M |
| Diluted Shares (Avg) | 735M+0.1% | 734M-0.1% | 735M-1.0% | 743M0.0% | 743M+0.8% | 737M0.0% | 737M-9.4% | 814M-6.0% | 866M |
Not reported in any period shown, so not listed: SG&A Expenses, EBITDA, EPS (Basic), EPS (Diluted).
IMOS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4B+4.5% | $1.4B-8.2% | $1.5B+3.1% | $1.5B-4.6% | $1.5B+22.7% | $1.2B+8.9% | $1.1B+6.0% | $1.1B-3.5% | $1.1B |
| Current Assets | $801.6M+11.2% | $721.1M-12.2% | $821.7M+37.6% | $597.2M+0.5% | $594.3M+35.1% | $440.0M+11.9% | $393.3M+1.3% | $388.4M-18.9% | $479.1M |
| Cash & Equivalents | $473.7M+2.1% | $464.1M+15.0% | $403.5M+25.3% | $322.1M+51.3% | $212.9M+45.3% | $146.5M-6.9% | $157.3M+3.7% | $151.7M-44.1% | $271.1M |
| Inventory | $107.0M+30.2% | $82.2M-2.0% | $83.9M-19.7% | $104.5M-9.6% | $115.6M+54.4% | $74.9M+26.7% | $59.1M+1.7% | $58.1M-10.7% | $65.1M |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $157.1M+14.4% | $137.4M |
| Total Liabilities | $681.1M+9.6% | $621.4M-11.1% | $698.8M+5.8% | $660.7M-0.3% | $662.6M+29.5% | $511.6M+3.6% | $494.0M+0.1% | $493.7M-3.3% | $510.8M |
| Current Liabilities | $334.1M+25.4% | $266.5M+9.7% | $242.9M+15.0% | $211.2M-20.9% | $267.1M+31.0% | $203.9M+21.5% | $167.8M-2.0% | $171.2M-26.9% | $234.2M |
| Non-Current Liabilities | $347.0M-2.2% | $354.9M-22.1% | $455.9M+1.4% | $449.5M+13.7% | $395.5M+28.5% | $307.7M-5.7% | $326.2M+1.1% | $322.5M+16.6% | $276.5M |
| Long-Term Debt | $23.6M-92.6% | $318.2M-23.0% | $413.1M+2.0% | $405.0M+19.9% | $337.7M+35.7% | $248.8M-10.3% | $277.3M-6.1% | $295.4M+16.8% | $253.0M |
| Total Equity | $764.7M+0.3% | $762.5M-5.7% | $808.7M+0.9% | $801.8M-7.9% | $870.3M+18.0% | $737.7M+13.0% | $653.0M+10.9% | $588.7M-3.7% | $611.4M |
| Retained Earnings | $248.4M-3.6% | $257.5M-6.7% | $276.1M-0.2% | $276.8M-9.9% | $307.2M+59.7% | $192.4M+23.7% | $155.5M+32.1% | $117.7M+23.9% | $95.0M |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill.
IMOS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $127.4M-29.7% | $181.2M-16.0% | $215.8M-23.0% | $280.4M+6.3% | $263.9M+24.7% | $211.5M+5.8% | $200.0M+48.3% | $134.9M-3.8% | $140.3M |
| Capital Expenditures | $122.8M-20.8% | $155.0M+54.4% | $100.4M-34.4% | $152.9M-27.9% | $212.0M+50.3% | $141.1M-22.5% | $181.9M+34.0% | $135.7M-14.1% | $158.0M |
| Free Cash Flow | $4.6M-82.3% | $26.2M-77.3% | $115.4M-9.5% | $127.5M+145.9% | $51.8M-26.4% | $70.5M+289.1% | $18.1Mn/m | -$817Kn/m | -$17.7M |
| Investing Cash Flow | -$119.2Mn/m | -$18.8Mn/m | -$100.9Mn/m | -$164.7Mn/m | -$216.8Mn/m | -$135.3Mn/m | -$141.7Mn/m | -$167.6Mn/m | -$117.9M |
| Financing Cash Flow | -$19.4Mn/m | -$75.5Mn/m | -$34.6M-355.0% | $13.6M-23.9% | $17.8Mn/m | -$96.9Mn/m | -$56.1Mn/m | -$78.4Mn/m | -$18.6M |
| Dividends Paid | $27.8M-30.3% | $39.9M-26.9% | $54.6M-46.3% | $101.8M+76.4% | $57.7M+23.7% | $46.6M+59.8% | $29.2M+247.8% | $8.4M-3.3% | $8.7M |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Share Buybacks.
IMOS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | 13.0%-3.6pp | 16.6%-4.3pp | 20.9%-5.6pp | 26.5%+4.6pp | 21.9%+2.6pp | 19.3%+0.7pp | 18.6%+0.5pp | 18.0% |
| Operating Margin | N/A | 5.6%-3.3pp | 8.9%-4.7pp | 13.7%-6.6pp | 20.3%+4.8pp | 15.5%+3.4pp | 12.1%+0.7pp | 11.4%-1.1pp | 12.5% |
| Net Margin | 2.3%-4.0pp | 6.3%-2.9pp | 9.2%-5.4pp | 14.6%-3.4pp | 18.0%+7.7pp | 10.3%-2.0pp | 12.3%+5.2pp | 7.2%-8.4pp | 15.6% |
| Return on Equity | 2.3%-3.5pp | 5.8%-2.2pp | 8.0%-6.0pp | 14.0%-6.5pp | 20.4%+9.0pp | 11.5%-1.4pp | 12.8%+5.5pp | 7.4%-8.1pp | 15.4% |
| Return on Assets | 1.2%-2.0pp | 3.2%-1.1pp | 4.3%-3.4pp | 7.6%-4.0pp | 11.6%+4.8pp | 6.8%-0.5pp | 7.3%+3.3pp | 4.0%-4.4pp | 8.4% |
| Current Ratio | 2.40-0.3x | 2.71-0.7x | 3.38+0.6x | 2.83+0.6x | 2.23+0.1x | 2.16-0.2x | 2.34+0.1x | 2.27+0.2x | 2.05 |
| Debt-to-Equity | 0.03-0.4x | 0.42-0.1x | 0.510.0x | 0.51+0.1x | 0.39+0.1x | 0.34-0.1x | 0.42-0.1x | 0.50+0.1x | 0.41 |
| Liabilities-to-Equity | 0.89+0.1x | 0.810.0x | 0.860.0x | 0.82+0.1x | 0.76+0.1x | 0.69-0.1x | 0.76-0.1x | 0.840.0x | 0.84 |
| Asset Turnover | 0.530.0x | 0.500.0x | 0.46-0.1x | 0.52-0.1x | 0.640.0x | 0.66+0.1x | 0.590.0x | 0.560.0x | 0.54 |
| FCF Margin | 0.6%-3.2pp | 3.8%-12.8pp | 16.6%-0.1pp | 16.7%+11.4pp | 5.3%-3.3pp | 8.6%+5.9pp | 2.7%+2.8pp | -0.1%+2.8pp | -2.9% |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| ChipMOS TECHNOLOGIES INC IMOS | FY2025 | $762.9M | $17.6M | 2.3% | $2.0B | 56/100 |
| CEVA Inc. CEVA | FY2025 | $109.6M | -$10.6M | -9.7% | $828.0M | 65/100 |
| Alpha and Omega Semiconductor Limited AOSL | FY2026 | $678.9M | -$42.3M | -6.2% | $665.8M | 45/100 |
| POET Technologies Inc. POET | FY2025 | $1.1M | -$63.0M | N/A | $929.3M | 53/100 |
| SEALSQ Corp LAES | FY2025 | $18.3M | -$34.2M | N/A | $341.9M | 45/100 |
Where ChipMOS TECHNOLOGIES INC Ranks
Frequently Asked Questions
What is ChipMOS TECHNOLOGIES INC's annual revenue?
ChipMOS TECHNOLOGIES INC (IMOS) reported $762.9M in total revenue for fiscal year 2025. This represents a 10.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is ChipMOS TECHNOLOGIES INC's revenue growing?
ChipMOS TECHNOLOGIES INC (IMOS) revenue grew by 10.2% year-over-year, from $692.2M to $762.9M in fiscal year 2025.
Is ChipMOS TECHNOLOGIES INC profitable?
Yes, ChipMOS TECHNOLOGIES INC (IMOS) reported a net income of $17.6M in fiscal year 2025, with a net profit margin of 2.3%.
How much debt does ChipMOS TECHNOLOGIES INC have?
As of fiscal year 2025, ChipMOS TECHNOLOGIES INC (IMOS) had $473.7M in cash and equivalents against $23.6M in long-term debt.
What is ChipMOS TECHNOLOGIES INC's net profit margin?
ChipMOS TECHNOLOGIES INC (IMOS) had a net profit margin of 2.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is ChipMOS TECHNOLOGIES INC's return on equity (ROE)?
ChipMOS TECHNOLOGIES INC (IMOS) has a return on equity of 2.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is ChipMOS TECHNOLOGIES INC's free cash flow?
ChipMOS TECHNOLOGIES INC (IMOS) generated $4.6M in free cash flow during fiscal year 2025. This represents a -82.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is ChipMOS TECHNOLOGIES INC's operating cash flow?
ChipMOS TECHNOLOGIES INC (IMOS) generated $127.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are ChipMOS TECHNOLOGIES INC's total assets?
ChipMOS TECHNOLOGIES INC (IMOS) had $1.4B in total assets as of fiscal year 2025, including both current and long-term assets.
What are ChipMOS TECHNOLOGIES INC's capital expenditures?
ChipMOS TECHNOLOGIES INC (IMOS) invested $122.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is ChipMOS TECHNOLOGIES INC's current ratio?
ChipMOS TECHNOLOGIES INC (IMOS) had a current ratio of 2.40 as of fiscal year 2025, which is generally considered healthy.
What is ChipMOS TECHNOLOGIES INC's debt-to-equity ratio?
ChipMOS TECHNOLOGIES INC (IMOS) had a debt-to-equity ratio of 0.03 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is ChipMOS TECHNOLOGIES INC's liabilities-to-equity ratio?
ChipMOS TECHNOLOGIES INC (IMOS) had a liabilities-to-equity ratio of 0.89 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is ChipMOS TECHNOLOGIES INC's return on assets (ROA)?
ChipMOS TECHNOLOGIES INC (IMOS) had a return on assets of 1.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is ChipMOS TECHNOLOGIES INC's P/E ratio?
ChipMOS TECHNOLOGIES INC (IMOS) trades at 114x earnings, its market capitalization divided by $17.6M net income, FY2025. The market capitalization is $2.0B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is ChipMOS TECHNOLOGIES INC's price-to-sales ratio?
ChipMOS TECHNOLOGIES INC (IMOS) trades at 2.6x sales, its market capitalization divided by $762.9M revenue, FY2025. The market capitalization is $2.0B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is ChipMOS TECHNOLOGIES INC's Piotroski F-Score?
ChipMOS TECHNOLOGIES INC (IMOS) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are ChipMOS TECHNOLOGIES INC's earnings high quality?
ChipMOS TECHNOLOGIES INC (IMOS) has an earnings quality ratio of 7.26x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is ChipMOS TECHNOLOGIES INC?
ChipMOS TECHNOLOGIES INC (IMOS) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.